Underinvestment in European Biotechnology

William Bains

Chapter 5 in Venture Capital and the European Biotechnology Industry, 2009, pp 55-72 from Palgrave Macmillan

Abstract: Abstract Why do new companies fail? We have looked briefly at aspects of management and entrepreneurship, the usual scapegoats for company failure. However, the objective evidence is that overwhelmingly companies fail through undercapitalisation.

Keywords: Venture Capital; Business Plan; Biotechnology Company; Global Entrepreneurship Monitor; Investee Company (search for similar items in EconPapers)
Date: 2009
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-22726-2_5

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230227262

DOI: 10.1057/9780230227262_5

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().